- Home
- HOWL vs GROV Comparison
HOWL vs GROV Comparison
Compare HOWL & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- GROV
- Stock Information
- Founded
- HOWL 2017
- GROV 2016
- Country
- HOWL United States
- GROV United States
- Employees
- HOWL N/A
- GROV N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- GROV Package Goods/Cosmetics
- Sector
- HOWL Health Care
- GROV Consumer Discretionary
- Exchange
- HOWL Nasdaq
- GROV Nasdaq
- Market Cap
- HOWL 47.1M
- GROV 53.5M
- IPO Year
- HOWL 2021
- GROV N/A
- Fundamental
- Price
- HOWL $1.36
- GROV $1.46
- Analyst Decision
- HOWL Strong Buy
- GROV Hold
- Analyst Count
- HOWL 3
- GROV 1
- Target Price
- HOWL $8.33
- GROV $1.20
- AVG Volume (30 Days)
- HOWL 554.2K
- GROV 556.3K
- Earning Date
- HOWL 08-07-2025
- GROV 08-07-2025
- Dividend Yield
- HOWL N/A
- GROV N/A
- EPS Growth
- HOWL N/A
- GROV N/A
- EPS
- HOWL N/A
- GROV N/A
- Revenue
- HOWL $1,143,000.00
- GROV $193,427,000.00
- Revenue This Year
- HOWL N/A
- GROV N/A
- Revenue Next Year
- HOWL N/A
- GROV $6.22
- P/E Ratio
- HOWL N/A
- GROV N/A
- Revenue Growth
- HOWL N/A
- GROV N/A
- 52 Week Low
- HOWL $0.60
- GROV $1.02
- 52 Week High
- HOWL $4.18
- GROV $1.95
- Technical
- Relative Strength Index (RSI)
- HOWL 60.96
- GROV 57.66
- Support Level
- HOWL $1.25
- GROV $1.42
- Resistance Level
- HOWL $1.44
- GROV $1.60
- Average True Range (ATR)
- HOWL 0.10
- GROV 0.13
- MACD
- HOWL 0.02
- GROV 0.01
- Stochastic Oscillator
- HOWL 68.89
- GROV 44.12
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.